101: External Radiation for HCC-External Radiation for HCC (101)

Video Transcription

Video Summary

The ASLB e-learning activity on external radiation for hepatocellular carcinoma (HCC) led by Dr. Andrew Moon and his team explores key aspects of radiation therapy, specifically external beam radiotherapy (EBRT) for liver cancer. Dr. Jeff Meyer elucidates the non-invasive nature of EBRT, contrasting it with brachytherapy. Proton therapy's advantage over X-rays due to its targeted delivery is highlighted, reducing damage to surrounding tissue. Fractionation techniques aid in minimizing harm to healthy tissues while focusing on tumors. Steriotactic body radiation therapy is compared to conventional methods through shorter, high-dose sessions. Patient suitability involves assessing tumor size, location, and liver health, particularly in cirrhosis cases. The management approach involves multidisciplinary discussions considering tumor characteristics and patient liver health. Post-treatment surveillance includes monitoring imaging and AFP levels. Finally, as immunotherapy evolves, the integration of EBRT aims at enhancing synergy in HCC management, emphasizing the importance of evidence and multidisciplinary collaboration.

Keywords

external beam radiotherapy

hepatocellular carcinoma

proton therapy

fractionation techniques

immunotherapy integration